611 related articles for article (PubMed ID: 33875860)
1. Novel approaches to target the microenvironment of bone metastasis.
Hofbauer LC; Bozec A; Rauner M; Jakob F; Perner S; Pantel K
Nat Rev Clin Oncol; 2021 Aug; 18(8):488-505. PubMed ID: 33875860
[TBL] [Abstract][Full Text] [Related]
2. Osteoblasts and osteoclasts: an important switch of tumour cell dormancy during bone metastasis.
Dai R; Liu M; Xiang X; Xi Z; Xu H
J Exp Clin Cancer Res; 2022 Oct; 41(1):316. PubMed ID: 36307871
[TBL] [Abstract][Full Text] [Related]
3. Disseminated tumour cells in bone marrow are the source of cancer relapse after therapy.
Sai B; Xiang J
J Cell Mol Med; 2018 Dec; 22(12):5776-5786. PubMed ID: 30255991
[TBL] [Abstract][Full Text] [Related]
4. Targeting Intercellular Communication in the Bone Microenvironment to Prevent Disseminated Tumor Cell Escape from Dormancy and Bone Metastatic Tumor Growth.
Kreps LM; Addison CL
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33805598
[TBL] [Abstract][Full Text] [Related]
5. Bone Metastasis: Molecular Mechanisms Implicated in Tumour Cell Dormancy in Breast and Prostate Cancer.
Quayle L; Ottewell PD; Holen I
Curr Cancer Drug Targets; 2015; 15(6):469-80. PubMed ID: 25968899
[TBL] [Abstract][Full Text] [Related]
6. Tumour dormancy in inflammatory microenvironment: A promising therapeutic strategy for cancer-related bone metastasis.
Hu W; Zhang L; Dong Y; Tian Z; Chen Y; Dong S
Cell Mol Life Sci; 2020 Dec; 77(24):5149-5169. PubMed ID: 32556373
[TBL] [Abstract][Full Text] [Related]
7. New therapeutic targets for cancer bone metastasis.
Krzeszinski JY; Wan Y
Trends Pharmacol Sci; 2015 Jun; 36(6):360-73. PubMed ID: 25962679
[TBL] [Abstract][Full Text] [Related]
8. Cancer Cell Colonisation in the Bone Microenvironment.
Kan C; Vargas G; Pape FL; Clézardin P
Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27782035
[TBL] [Abstract][Full Text] [Related]
9. Bone marrow niches in the regulation of bone metastasis.
Chen F; Han Y; Kang Y
Br J Cancer; 2021 Jun; 124(12):1912-1920. PubMed ID: 33758331
[TBL] [Abstract][Full Text] [Related]
10. Angiocrine signals regulate quiescence and therapy resistance in bone metastasis.
Singh A; Veeriah V; Xi P; Labella R; Chen J; Romeo SG; Ramasamy SK; Kusumbe AP
JCI Insight; 2019 Jul; 4(13):. PubMed ID: 31292293
[TBL] [Abstract][Full Text] [Related]
11. Emerging therapies in bone metastasis.
Clément-Demange L; Clézardin P
Curr Opin Pharmacol; 2015 Jun; 22():79-86. PubMed ID: 25935860
[TBL] [Abstract][Full Text] [Related]
12. Circulating and disseminated tumor cells: harbingers or initiators of metastasis?
Dasgupta A; Lim AR; Ghajar CM
Mol Oncol; 2017 Jan; 11(1):40-61. PubMed ID: 28085223
[TBL] [Abstract][Full Text] [Related]
13. Single cell mutational analysis of PIK3CA in circulating tumor cells and metastases in breast cancer reveals heterogeneity, discordance, and mutation persistence in cultured disseminated tumor cells from bone marrow.
Deng G; Krishnakumar S; Powell AA; Zhang H; Mindrinos MN; Telli ML; Davis RW; Jeffrey SS
BMC Cancer; 2014 Jun; 14():456. PubMed ID: 24947048
[TBL] [Abstract][Full Text] [Related]
14. Bone metastases.
Coleman RE; Croucher PI; Padhani AR; Clézardin P; Chow E; Fallon M; Guise T; Colangeli S; Capanna R; Costa L
Nat Rev Dis Primers; 2020 Oct; 6(1):83. PubMed ID: 33060614
[TBL] [Abstract][Full Text] [Related]
15. Exploiting bone niches: progression of disseminated tumor cells to metastasis.
Muscarella AM; Aguirre S; Hao X; Waldvogel SM; Zhang XH
J Clin Invest; 2021 Mar; 131(6):. PubMed ID: 33720051
[TBL] [Abstract][Full Text] [Related]
16. Heterogeneity of tumor cells in the bone microenvironment: Mechanisms and therapeutic targets for bone metastasis of prostate or breast cancer.
Futakuchi M; Fukamachi K; Suzui M
Adv Drug Deliv Rev; 2016 Apr; 99(Pt B):206-211. PubMed ID: 26656603
[TBL] [Abstract][Full Text] [Related]
17. Evolving cancer-niche interactions and therapeutic targets during bone metastasis.
Satcher RL; Zhang XH
Nat Rev Cancer; 2022 Feb; 22(2):85-101. PubMed ID: 34611349
[TBL] [Abstract][Full Text] [Related]
18. Targeting the Hepatocyte Growth Factor and c-Met Signaling Axis in Bone Metastases.
Whang YM; Jung SP; Kim MK; Chang IH; Park SI
Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30658428
[TBL] [Abstract][Full Text] [Related]
19. Circulating and disseminated tumour cells - mechanisms of immune surveillance and escape.
Mohme M; Riethdorf S; Pantel K
Nat Rev Clin Oncol; 2017 Mar; 14(3):155-167. PubMed ID: 27644321
[TBL] [Abstract][Full Text] [Related]
20. The Roles of Bone Marrow-Resident Cells as a Microenvironment for Bone Metastasis.
Shiozawa Y
Adv Exp Med Biol; 2020; 1226():57-72. PubMed ID: 32030676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
